Inflammatix, INC. R & d for triverity cartridge development AOI #2 (infection severity and solving sepsis)
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00069
- Awardee
-
Inflammatix, Inc. UEI WK9MLMSHBVL3
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $749,999
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $749,999.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Hillsborough, CA 94010, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $749,999 |
About this award
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The contract has a period of performance through March 31, 2025. Inflammatix has a history of federal contract and grant awards from HHS agencies, including over $29 million in support for the development of other diagnostic solutions for acute infections, sepsis, and COVID-19.
Quick answers
Who was awarded contract 75A50122C00069?
75A50122C00069 was awarded to Inflammatix, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 14, 2022.
How much is contract 75A50122C00069 worth?
The government has obligated $749,999 on 75A50122C00069.
Was contract 75A50122C00069 competed?
The extent of competition for 75A50122C00069 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award